Search

Author/Creator Dummer, Reinhard

21. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. Issue 5 (May 2021)

Authors:
Eggermont, Alexander M M; Blank, Christian U; Mandalà, Mario; Long, Georgina V; Atkinson, Victoria G; Dalle, Stéphane; Haydon, Andrew M; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A; Rutkowski, Piotr; Schadendorf, Dirk;...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 5(2021)
Page Start:
643
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

22. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial. Issue 5 (May 2021)

Authors:
Bottomley, Andrew; Coens, Corneel; Mierzynska, Justyna; Blank, Christian U; Mandalà, Mario; Long, Georgina V; Atkinson, Victoria G; Dalle, Stéphane; Haydon, Andrew M; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Puig, Susana; Ascierto, Paolo A; Larkin, James; Loriga...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 5(2021)
Page Start:
655
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

26. Adverse events 2.0—Let us get SERIOs: New reporting for adverse event outcomes needed in the era of immunooncology. (May 2019)

Authors:
Heinzerling, Lucie; Ascierto, Paolo A.; Dummer, Reinhard; Gogas, Helen; Grob, Jean-Jacques; Lebbe, Celeste; Long, Georgina V.; McArthur, Grant; Moslehi, Javid J.; Neilan, Tomas G.; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; Wolchok, Jedd D.; Hauschild, Axel
Journal:
European journal of cancer
Issue:
Volume 112(2019)
Page Start:
29
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

27. Aggressive rare T cell lymphomas with manifestation in the skin: A monocentric cross-sectional case study. (September 2018)

Authors:
Brüggen, Marie-Charlotte; Kerl, Katrin; Haralambieva, Eugenia; Schanz, Urs; Chang, Yun-Tsan; Ignatova, Desislava; Dummer, Reinhard; Cozzio, Antonio; Hoetzenecker, Wolfram; French, Lars; Guenova, Emmanuella
Journal:
European journal of cancer
Issue:
Volume 101(2018)Supplement 1
Page Start:
S18
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

29. Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients. Issue 1 (20th February 2019)

Authors:
Fässler, Mirjam; Diem, Stefan; Mangana, Joanna; Hasan Ali, Omar; Berner, Fiamma; Bomze, David; Ring, Sandra; Niederer, Rebekka; del Carmen Gil Cruz, Cristina; Pérez Shibayama, Christian Ivan; Krolik, Michal; Siano, Marco; Joerger, Markus; Recher, Mike; Risch, Lorenz; Güsewell, Sabine; Risch, Mart...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

30. Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study. Issue 9 (September 2022)

Authors:
Dummer, Reinhard; Queirolo, Paola; Abajo Guijarro, Ana Maria; Hu, Youyou; Wang, Dao; de Azevedo, Sergio Jobim; Robert, Caroline; Ascierto, Paolo Antonio; Chiarion-Sileni, Vanna; Pronzato, Paolo; Spagnolo, Francesco; Mujika Eizmendi, Karmele; Liszkay, Gabriella; de la Cruz Merino, Luis; Tawbi, Hus...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 9(2022)
Page Start:
1145
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗